INDICATION AUCATZYL ® is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory B-cell precursor acute ...

GSK plc ( GSK) Q3 2025 Earnings Call October 29, 2025 8:00 AM EDT Ladies and gentlemen, a very warm welcome to the GSK Q3 2025 Results Call. I'm delighted to be joined today by Emma Walmsley, Luke ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates ...

Accenture (NYSE: ACN) invests in Lyzr, an AI platform for enterprises in banking, insurance, and financial services.

BOSTON and LONDON, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...

Franco-Nevada's record quarterly results benefited from a combination of higher gold prices, strong operations, new acquisitions and the sale of Cobre Panama copper concentrate stockpiles. Our ...

Q3 2025 Earnings Call Transcript October 29, 2025 Smurfit Westrock Plc misses on earnings expectations. Reported EPS is $0.55 EPS, expectations were $0.68. Operator: Good day, and thank you for ...

Lyzr will join Accenture Ventures’ Project Spotlight, a vertical accelerator program that provides AI companies with access ...

QPR SOFTWARE PLC STOCK EXCHANGE RELEASE 31 October 2025, AT 9.00 AM EETQPR Software Plc Interim Report January-September 2025: The company's SaaS net sales grew by 2%. QPR ProcessAnalyzer's ...

The long-standing practice of lenders paying car dealers to sell their loans ... to wrongly charged customers. The program is set to cost the industry a further £2.8 billion to implement. The lenders ...

Lyzr will join Accenture Ventures’ Project Spotlight, a vertical accelerator program that provides AI companies with access to Accenture’s domain expertise and enterprise clients. The company is also ...